Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 1,002.05
+22.00 (2.24%)
Aug 21, 2026, 3:30 PM IST
Orchid Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 50,823 | 24,469 | 39,363 | 52,994 | 15,643 | 11,641 | |
Market Cap Growth | 32.24% | -37.84% | -25.72% | 238.77% | 34.38% | -88.15% |
Enterprise Value | 53,617 | 25,800 | 38,574 | 53,964 | 18,909 | 14,449 |
Last Close Price | 1002.05 | 482.45 | 776.10 | 1044.85 | 383.25 | 285.20 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 172.37 | 119.09 | 39.50 | 57.50 | 33.77 | - |
Forward PE | 43.90 | 24.18 | 29.60 | 41.04 | - | - |
PS Ratio | 5.96 | 3.02 | 4.27 | 6.47 | 2.35 | 2.08 |
PB Ratio | 3.95 | 1.90 | 3.11 | 4.53 | 2.27 | 1.80 |
P/TBV Ratio | 4.19 | 2.02 | 3.15 | 4.59 | 2.27 | 1.80 |
P/FCF Ratio | - | - | - | 86.62 | - | 14.91 |
P/OCF Ratio | 50.22 | 24.18 | 204.86 | 42.06 | 85.30 | 12.59 |
PEG Ratio | 1.63 | 0.87 | 0.77 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 6.29 | 3.18 | 4.18 | 6.59 | 2.84 | 2.58 |
EV/EBITDA Ratio | 90.12 | 62.73 | 32.97 | 49.33 | 22.57 | 27.21 |
EV/EBIT Ratio | 226.33 | 454.59 | 46.50 | 69.52 | 65.22 | - |
EV/FCF Ratio | - | - | - | 88.21 | - | 18.51 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.28 | 0.28 | 0.14 | 0.12 | 0.48 | 0.41 |
Debt / EBITDA Ratio | 7.11 | 8.82 | 1.49 | 1.23 | 3.96 | 5.05 |
Debt / FCF Ratio | - | - | - | 2.21 | - | 3.43 |
Net Debt / Equity Ratio | 0.22 | 0.22 | 0.12 | 0.11 | 0.44 | 0.41 |
Net Debt / EBITDA Ratio | 5.48 | 6.79 | 1.31 | 1.20 | 3.64 | 4.97 |
Net Debt / FCF Ratio | - | -0.99 | -1.17 | 2.15 | -4.58 | 3.38 |
Asset Turnover | - | 0.45 | 0.57 | 0.59 | 0.57 | 0.48 |
Inventory Turnover | - | 1.81 | 1.92 | 2.04 | 2.00 | 2.01 |
Quick Ratio | - | 1.25 | 0.93 | 0.79 | 0.65 | 0.73 |
Current Ratio | - | 2.45 | 2.83 | 3.04 | 1.35 | 1.65 |
Return on Equity (ROE) | - | 1.61% | 8.18% | 9.92% | 7.95% | -9.29% |
Return on Assets (ROA) | - | 0.20% | 3.20% | 3.49% | 1.55% | -1.80% |
Return on Capital Employed (ROCE) | - | 0.30% | 5.90% | 6.00% | 3.40% | -3.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.58% | 0.84% | 2.53% | 1.74% | 2.96% | -0.17% |
FCF Yield | -5.56% | -11.54% | -3.33% | 1.15% | -4.26% | 6.71% |
Buyback Yield / Dilution | 0.08% | -0.03% | -4.87% | -18.49% | - | - |